| Returns | 1W : 5.6% , 1M : 4.4%,1Y : 21.9% |
| Peers & Returns | 1W | 1M | 1Y |
| INDRAPRASTHA MEDICAL CORPORATION LTD | 5.6% | 4.4% | 21.9% |
| APOLLO HOSPITALS ENTERPRISE LTD | 2.9% | 14.4% | 61.9% |
| DR LAL PATHLABS LTD | 7% | -0.3% | 39.4% |
| FORTIS HEALTHCARE LTD | 0.3% | 12.4% | -4.3% |
| METROPOLIS HEALTHCARE LTD | 10.6% | 15.4% | 50.1% |
| ASTER DM HEALTHCARE LTD | 0.9% | 18.4% | 17.6% |
| NARAYANA HRUDAYALAYA LTD | 1.4% | 10.7% | 22.6% |
| THYROCARE TECHNOLOGIES LTD | 5.1% | 2.9% | 88.7% |
| SHALBY LTD | 9.5% | 10.5% | -11% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
10.9
P/E Calculated based on EPS of 4.76
[ Mar2020 - Standalone Results ] 1.78
P/B Calculated based on Book Value of 29.21
[ Mar2020 - Standalone Results ] 0.66
P/S Calculated based on Revenues of 721.29 Cr
[ TTM - Standalone Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
-4% -18% -0% |
| Year | Debt/Equity ratio | |
|---|---|---|
|
Debt/Equity ratio analysis
For all non-Banking industries, Good = Ratio less than 0.4 Average = Ratio between 0.4 and 0.6 Bad = Ratio greater than 0.6 Worst is considered between Standalone & Consolidated |
Standalone | Consolidated |
|
2020 2019 2018 Avg_3yrs |
0.01 0.09 0.28 0.13 |
- - - - |
|
[Last Annual Data : Mar2020]
|
||
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
| Standalone | 1 Qtr Growth | 4 Qtr Growth |
|---|---|---|
|
Revenue Op Profit EBIDT Net Income |
49.75% -138.47% -101.27% -101.74% |
-34.73% -57.83% -96.66% -97.56% |
| QtrlyTrend |
-6
Quarterly Trend analysis
The growth rate score are assigned as under: If ratio's 1Q growth is +ve, then 1. If -ve, then -1. If ratio's 4Q growth is +ve, then 1.If -ve, then -1. Growth Score= Sum of all the above scores for Revenue, Operating Profit and Net Income. Interpretation Good = Growth Score >=4 Neutral = Growth Score between 0 and 4 Bad = Growth Score less than 0 |
|
| Latest Qtr: Sep2020 | ||
